Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients

Survival of patients with B cell chronic lymphocytic leukemia (B-CLL) can be predicted by analysis of mutations in the immunoglobulin heavy chain variable gene (IGHV). Patients without mutations (unmutated [UM]) are at greater risk for disease progression and death than patients with mutations (M)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tschumper, Renee C., Geyer, Susan M., Campbell, Megan E., Kay, Neil E., Shanafelt, Tait D., Zent, Clive S., Nowakowski, Grzegorz S., Call, Timothy G., Dewald, Gordon W., Jelinek, Diane F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2007
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2117767/
https://ncbi.nlm.nih.gov/pubmed/18064298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32625
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars